Our mission is to discover treatments and a cure for ALS, and to serve, advocate for, and empower people affected by ALS to live their lives to the fullest.
The Milton Safenowitz Postdoctoral Fellowship Program, established by The ALS Association, aims to attract and retain bright, young scientists in the ALS research field to foster the development of innovative treatments and ultimately find a cure. The program awards fellows up to $150,000 over two years to conduct research with high scientific merit and relevance to ALS. Established in memory of Milton Safenowitz by his family, the program encourages fellows to engage with the ALS research community, develop high-quality publications, and gather preliminary data to support further funding applications. This fellowship has a significant track record, with approximately 75% of recipients continuing their research in ALS, contributing to the field through academia, industry, or related sectors. Projects of interest for funding include new target validations, disease-relevant model studies, risk reduction strategies, new biomarker identification, ALS management innovations, and analysis of -omics data to uncover therapeutic targets or biomarkers.